eSource has long been touted as the solution to high data management and monitoring costs and inefficiencies. This webinar will cover the history of eSource, the reasons it did not take off as quickly as people initially expected, and where eSource is headed. From EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically for clinical trials and then re-purposing it for downstream analysis, at a far higher volume than usual due to COVID-19.
eSource has the potential to change the antiquated process of capturing data during a clinical trial. The effect on the efficiency of monitoring, site, and data management processes is significant. Join this webinar to hear first-hand how one CRO leveraged eSource to lower overall costs for sites, data management, and monitoring.
This webinar will provide a grounding in what eSource is, how it can be deployed, the practical implementation of eSource, and how to avoid hurdles in the process.
SVP Business Development, and Commercial Strategy, Quartesian
As SVP business development and commercial strategy, Stephen Boccardo handles all aspects of customer business development. He combines more than 30 years of life science industry experience and dedicated technology expertise with a record of success on the clinical data management and systems side as well as growing startup organizations through sales and marketing leadership. Mr. Boccardo joined Quartesian from Clinical Ink where he served as Chief Commercial Officer. In this role, he was responsible for all Clinical Ink global sales and marketing activities to drive market adoption of the company’s industry-leading eSource products and solutions.
Product Manager of Participant Engagement, ePro and eConsent, Medrio
Lisa Charlton brings a wealth of clinical research and business experience to her role as Customer Success Manager at Medrio. With an extensive background in structural biology, she has worked as contributing investigator and author of nine peer-reviewed publications and helped earn a patent for a biomedical device. She has also spent six years in the eClinical industry, supporting and consulting for clinical outcome assessments as well as assisting with eCOA implementation and design. Lisa holds a Ph.D. in Biological Chemistry from the University of North Carolina at Chapel Hill and an MBA from Point Park University, Pittsburgh.